首页 › 基金 › NVP Associates, LLC › ZBIO

NVP Associates, LLC 对 ZBIO 的持仓历史

ZENAS BIOPHARMA INC · 医疗保健

NVP Associates, LLC 在 Q3 2026 的 13F 申报中披露持有 ZBIO(ZENAS BIOPHARMA INC)1,838,482 股,市值约 US$49.6M,约占其申报组合的 17.59%,在其申报持仓中市值排名第 3 位。 NVP Associates, LLC 最近 9 个申报季度中有 9 个季度披露了 ZBIO 持仓,最早可追溯至 Q3 2024。

最新持仓 (Q3 2026)1.84M 股
申报持仓市值$49.58M
组合权重17.59%
首次申报Q3 2024
最近变动持有
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

NVP Associates, LLC 对 ZBIO 的持仓演变

NVP Associates, LLC 于 Q3 2024 首次披露 ZBIO 持仓:1,838,482 股(约 US$31.1M)。 该持仓在 Q4 2025 达到峰值 1,838,482 股,市值约 US$66.8M。 在 9 次申报中,NVP Associates, LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 1,838,482 股、市值约 US$49.6M。

逐季持仓明细

季度股数金额变化
Q3 2024 1.84M $31.11M 新进
Q4 2024 1.84M $15.06M 持有
Q1 2025 1.84M $14.52M 持有
Q2 2025 1.84M $17.81M 持有
Q3 2025 1.84M $40.81M 持有
Q4 2025 1.84M $66.76M 持有
Q1 2026 1.84M $35.94M 持有
Q2 2026 1.84M $46.66M 持有
Q3 2026 1.84M $49.58M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ZBIO 与 13F 数据

ZBIO(ZENAS BIOPHARMA INC)属于医疗保健行业。我们追踪的基金中还有 63 只申报持有 ZBIO,申报仓位最大的包括:SR ONE CAPITAL MANAGEMENT, LP (US$127.9M), NEA Management Company, LLC (US$102.1M), Enavate Sciences GP, LLC (US$99.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ZBIO 的基金

查看 ZBIO 的全部基金持有人 →

常见问题

How long has NVP Associates, LLC held ZBIO?

NVP Associates, LLC has disclosed ZBIO holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is NVP Associates, LLC's current position in ZBIO?

As of Q3 2026, NVP Associates, LLC holds 1.84M shares of ZBIO (ZENAS BIOPHARMA INC), valued at $49.58M, representing 17.59% of its reported portfolio and ranking #3.

Has NVP Associates, LLC been buying or selling ZBIO?

In the latest 13F filing (Q3 2026), NVP Associates, LLC held unchanged its position in ZBIO. The position peaked in Q4 2025 at 1.84M shares.

Which other funds hold ZBIO?

Other major institutional holders of ZBIO include SR ONE CAPITAL MANAGEMENT, LP, NEA Management Company, LLC, Enavate Sciences GP, LLC, among 63 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.